TAFAZZIN and non-small cell lung carcinoma: The sequence adjacent to the SFTA1P transcription start site (TSS) contains seven consensus TEAD binding sites, and SFTA1P can exhibit YAP/TAZ/TEAD-dependent promoter activity in NSCLC cell lines.